z-logo
Premium
Efficacy of 18F‐fluorodeoxyglucose positron emission tomography/CT imaging for extracapsular spread of laryngeal squamous cell carcinoma
Author(s) -
Chun ByungJoon,
Yoo IeRyung,
Joo YoungHoon,
Nam InnChul,
Cho JungHae,
Kim ChungSu,
Cho KwangJae,
Kim MinSik
Publication year - 2016
Publication title -
head and neck
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.012
H-Index - 127
eISSN - 1097-0347
pISSN - 1043-3074
DOI - 10.1002/hed.23889
Subject(s) - medicine , positron emission tomography , fluorodeoxyglucose , standardized uptake value , lymph node , radiology , cervical cancer , nuclear medicine , laryngeal neoplasm , metastasis , carcinoma , cancer , pathology
Background We evaluated the use of fluorodeoxyglucose (FDG) positron emission tomography (PET)/CT for the identification of extracapsular spread (ECS) with supporting histologic correlations in laryngeal cancer. Methods We reviewed the medical records of 89 patients with laryngeal cancer who underwent FDG PET/CT before surgery. Results ECS was present in 38.2% (18 of 47) of dissected necks and in 32.2% (20 of 62) of dissected cervical levels. There was a significant difference in the standardized uptake value maximum (SUV max ) between cervical lymph nodes with and without ECS (6.39 ± 4.53 vs 1.21 ± 1.70; p < .001); the cutoff value for differentiating nodes with ECS from those without ECS was 2.8, with a sensitivity of 85.7% and specificity of 85.6%. Conclusion A median SUV max cutoff value >2.8 was associated with an increased risk of cervical lymph node metastasis and ECS in patients with laryngeal cancer. © 2014 Wiley Periodicals, Inc. Head Neck 38: 290–293, 2016

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom